Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A BOND

Showing results (661-670 of 682) with videos related to

Pageof 69
Sort By:
Blood Advances|May 12, 2023
High-grade B-cell lymphoma, not otherwise specified: a multi-institutional retrospective studyAdam S Zayac, Daniel J Landsburg, Mitchell E Hughes, et al.
Leukemia & Lymphoma|March 24, 2023
EBV-positive PCNSL in older patients: incidence, characteristics, tumor pathology, and outcomes across a large multicenter cohortPrashasti Agrawal, Kevin A David, Zhengming Chen, et al.
Blood Cancer Journal|February 20, 2025
Outcomes of patients with Richter transformation who received no prior chemoimmunotherapy for their CLLAdam S Kittai, Ying Huang, Sarah Miller, et al.
Blood|July 15, 2020
Burkitt lymphoma in the modern era: real-world outcomes and prognostication across 30 US cancer centersAndrew M Evens, Alexey Danilov, Deepa Jagadeesh, et al.
Blood Advances|July 20, 2021
HIV-associated Burkitt lymphoma: outcomes from a US-UK collaborative analysisJuan Pablo Alderuccio, Adam J Olszewski, Andrew M Evens, et al.
Haematologica|February 4, 2021
Outcomes of Burkitt lymphoma with central nervous system involvement: evidence from a large multicenter cohort studyAdam S Zayac, Andrew M Evens, Alexey Danilov, et al.
Cell Reports. Medicine|April 8, 2023
Robust SARS-CoV-2 T cell responses with common TCRαβ motifs toward COVID-19 vaccines in patients with hematological malignancy impacting B cellsThi H O Nguyen, Louise C Rowntree, Lilith F Allen, et al.
Blood Advances|February 24, 2026
Benefit of rituximab maintenance after first-line bendamustine-rituximab in patients with mantle cell lymphomaYucai Wang, Melissa C Larson, Steven R Hwang, et al.
Science (New York, N.Y.)|July 5, 2014
Exoplanet detection. A terrestrial planet in a ~1-AU orbit around one member of a ~15-AU binaryA Gould, A Udalski, I-G Shin, et al.
Blood Advances|December 11, 2025
Benefit of Rituximab Maintenance After First-line Bendamustine-Rituximab in Patients with Mantle Cell LymphomaYucai Wang, Melissa C Larson, Steven R Hwang, et al.
Pageof 69

Showing results (661-670 of 682) with videos related to

Sort By:
Pageof 69
Blood Advances|May 12, 2023
High-grade B-cell lymphoma, not otherwise specified: a multi-institutional retrospective studyAdam S Zayac, Daniel J Landsburg, Mitchell E Hughes, et al.
Leukemia & Lymphoma|March 24, 2023
EBV-positive PCNSL in older patients: incidence, characteristics, tumor pathology, and outcomes across a large multicenter cohortPrashasti Agrawal, Kevin A David, Zhengming Chen, et al.
Blood Cancer Journal|February 20, 2025
Outcomes of patients with Richter transformation who received no prior chemoimmunotherapy for their CLLAdam S Kittai, Ying Huang, Sarah Miller, et al.
Blood|July 15, 2020
Burkitt lymphoma in the modern era: real-world outcomes and prognostication across 30 US cancer centersAndrew M Evens, Alexey Danilov, Deepa Jagadeesh, et al.
Blood Advances|July 20, 2021
HIV-associated Burkitt lymphoma: outcomes from a US-UK collaborative analysisJuan Pablo Alderuccio, Adam J Olszewski, Andrew M Evens, et al.
Haematologica|February 4, 2021
Outcomes of Burkitt lymphoma with central nervous system involvement: evidence from a large multicenter cohort studyAdam S Zayac, Andrew M Evens, Alexey Danilov, et al.
Cell Reports. Medicine|April 8, 2023
Robust SARS-CoV-2 T cell responses with common TCRαβ motifs toward COVID-19 vaccines in patients with hematological malignancy impacting B cellsThi H O Nguyen, Louise C Rowntree, Lilith F Allen, et al.
Blood Advances|February 24, 2026
Benefit of rituximab maintenance after first-line bendamustine-rituximab in patients with mantle cell lymphomaYucai Wang, Melissa C Larson, Steven R Hwang, et al.
Science (New York, N.Y.)|July 5, 2014
Exoplanet detection. A terrestrial planet in a ~1-AU orbit around one member of a ~15-AU binaryA Gould, A Udalski, I-G Shin, et al.
Blood Advances|December 11, 2025
Benefit of Rituximab Maintenance After First-line Bendamustine-Rituximab in Patients with Mantle Cell LymphomaYucai Wang, Melissa C Larson, Steven R Hwang, et al.
Pageof 69